Hatteras Venture Partners VII

About Hatteras Venture Partners VII

Biotechnology, Medical Devices, Health Technology, Life Sciences, Diagnostics focused fund

Investment Focus

Location / RegionUnited States

Funding StageSeed

Industry Focus

Biotech

Diagnostics

Digital Health

Med Tech

Investor Signals Profile

active

Sweet Spot

Early-stage biotech/medtech founder with breakthrough patient impact

biotech

medtech

healthtech

early-stage

Southeast US + national

Bullish Signals

100+ companies built, 25+ yearsexternal

Full-stack support: team, BD, regulatoryexternal

Health-only focus, early-stage leadexternal

Research Triangle base, national footprintexternal

Multiple liquidity paths via networkexternal

Dedicated funds structure confirmedwebsite

Targets institutional LPs + entrepreneurswebsite

Contrarian Signals

Southeast-regional, limited coastal presenceexternal

No GP names publicly listedexternal

Team page gated — no public profileswebsite

Founder Do's

Show breakthrough science + strong team

Be based in or open to Southeast

Demonstrate clear patient impact

Expect active hands-on partnership

Have regulatory/clinical path ready

Founder Don'ts

Don't pitch non-healthcare sectors

Don't expect passive capital only

Don't skip value inflection milestones

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size$200M+

Saves0

Website

Key People

John Crumpler, Kenneth Lee, Michael Dial, Clay Thorp